BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35354585)

  • 1. Screening high risk populations for lung cancer.
    Melzer AC; Triplette M
    BMJ; 2022 Mar; 376():o666. PubMed ID: 35354585
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention and screening for lung cancers].
    Gounant V
    Rev Prat; 2020 Oct; 70(8):843. PubMed ID: 33739680
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of Diabetes Mellitus on Lung Cancer Screening Efficacy in the National Lung Screening Trial.
    Young RP; Scott RJ; Ward RC; Silvestri GA
    Chest; 2024 Jan; 165(1):224-228. PubMed ID: 37562538
    [No Abstract]   [Full Text] [Related]  

  • 4. Is Lung Cancer Screening Reaching the People Who Are Most Likely to Benefit?
    Braithwaite D; Gould MK
    JAMA Netw Open; 2022 Nov; 5(11):e2243171. PubMed ID: 36409500
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prevention and screening for lung cancers: 10 key messages].
    Gounant V
    Rev Prat; 2020 Oct; 70(8):868. PubMed ID: 33739689
    [No Abstract]   [Full Text] [Related]  

  • 6. [Lung cancer: progress in diagnosis and treatments. Topics I. Epidemiology and pathogenesis; 1. Epidemiology, prevention and screening].
    Saika K; Sobue T
    Nihon Naika Gakkai Zasshi; 2014 Jun; 103(6):1255-60. PubMed ID: 25151787
    [No Abstract]   [Full Text] [Related]  

  • 7. Harmonizing lung cancer screening guidelines.
    Nicholas J
    J Natl Cancer Inst; 2012 Oct; 104(20):1531-2. PubMed ID: 23044381
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening strategies for early detection of lung cancer: the time is now.
    Petty TL
    JAMA; 2000 Oct; 284(15):1977-80. PubMed ID: 11035898
    [No Abstract]   [Full Text] [Related]  

  • 9. A different interpretation of the efficacy of lung cancer screening in the PLCO trial.
    Sagawa M; Nakayama T; Sobue T;
    Eur J Epidemiol; 2016 Feb; 31(2):211-2. PubMed ID: 26197850
    [No Abstract]   [Full Text] [Related]  

  • 10. Screening for lung cancer.
    Ngo-Metzger Q; Fan T
    Am Fam Physician; 2014 Jul; 90(2):117-8. PubMed ID: 25077586
    [No Abstract]   [Full Text] [Related]  

  • 11. Complementary Roles of Screening and Nodule Programs for Early Detection of Lung Cancer in Diverse Populations.
    Bailey J; Van Haren RM
    Ann Surg Oncol; 2022 Sep; 29(9):5347-5349. PubMed ID: 35691956
    [No Abstract]   [Full Text] [Related]  

  • 12. Promoting Community Awareness of Lung Cancer Screening Among Disparate Populations: Results of the cancer-Community Awareness Access Research and Education Project.
    Williams LB; Looney SW; Joshua T; McCall A; Tingen MS
    Cancer Nurs; 2021 Mar-Apr 01; 44(2):89-97. PubMed ID: 31599751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk model-based lung cancer screening.
    Nierengarten MB
    Cancer; 2023 Jun; 129(11):1628. PubMed ID: 37158642
    [No Abstract]   [Full Text] [Related]  

  • 14. Lung Cancer Screening Eligibility in the Community: Cardiovascular Risk Factors, Coronary Artery Calcification, and Cardiovascular Events.
    Lu MT; Onuma OK; Massaro JM; D'Agostino RB; O'Donnell CJ; Hoffmann U
    Circulation; 2016 Sep; 134(12):897-9. PubMed ID: 27647299
    [No Abstract]   [Full Text] [Related]  

  • 15. Screening for Lung Cancer in Arkansas.
    Meek M; Frost A; Franklin P; Steliga M
    J Ark Med Soc; 2015 Nov; 112(7):108-9. PubMed ID: 26625603
    [No Abstract]   [Full Text] [Related]  

  • 16. Lung cancer screening in Australia: progress or procrastination?
    Brims F; McWilliams A; Fong K
    Med J Aust; 2016 Jan; 204(1):4-5. PubMed ID: 26763803
    [No Abstract]   [Full Text] [Related]  

  • 17. CT screening for lung cancer: Are we ready to implement in Europe?
    Balata H; Evison M; Sharman A; Crosbie P; Booton R
    Lung Cancer; 2019 Aug; 134():25-33. PubMed ID: 31319989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung cancer screening.
    Petty TL
    Compr Ther; 1995 Aug; 21(8):432-7. PubMed ID: 8536443
    [No Abstract]   [Full Text] [Related]  

  • 19. Democratic and ethical problem of lung cancer screening: exclusion of true high-risk populations. Can it be fixed? Yes.
    Røe OD
    BMJ Open Respir Res; 2020 Dec; 7(1):. PubMed ID: 33323364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening for lung cancer].
    Barta P; Losonczy G
    Orv Hetil; 2012 Jun; 153(23):904-7. PubMed ID: 22668591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.